Skip to main content

Advertisement

Table 2 Comparison of early termination and on-schedule completion of RRT in the AN69 and AN69ST groups

From: Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study

  RRT completed on schedule RRT early terminated
RRT time (min) 543.1 ± 118.9   387.3 ± 140.8  
  AN69 AN69 ST P value AN69 AN69 ST P value
  567.1 ± 119.9 548.3 ± 128.2 NS 366.9 ± 139.7 404.8 ± 142.0 NS
BFR ml/min 205.2 ± 16.9 202.4 ± 10.9 NS 206.5 ± 22.9 206.2 ± 22.8 NS
UF ml 2161.9 ± 908.0 2142.9 ± 1073.6 NS 1795.8 ± 1204.1 1751.8 ± 948.7 NS
Before RRT
 PLT X10^9 115.9 ± 83.0 108.7 ± 71.7 NS 145.5 ± 109.2 132.4 ± 73.5 NS
 Hb g/L 83.1 ± 10.4 81.7 ± 14.3 NS 90.8 ± 13.6 87.4 ± 15.0 NS
 WBC X10^9 9.37 ± 4.58 9.46 ± 4.81 NS 11.8 ± 13.8 10.9 ± 6.8 NS
 PT s 13.71 ± 4.91 13.25 ± 3.65 NS 13.2 ± 1.7 13.0 ± 2.2 NS
 APTT s 42.41 ± 20.80 42.71 ± 30.0 NS 36.2 ± 9.9 34.4 ± 11.2 NS
 ALB g/L 31.3 ± 4.16 32.0 ± 4.1 NS 28.4 ± 5.9 28.5 ± 4.3 NS
 SCr umol/L 356.1 ± 260.5 402.0 ± 288.8 NS 338.9 ± 175.0 381.0 ± 251.3 NS
 BUN mmol/L 19.24 ± 9.00 21.70 ± 7.53 NS 20.6 ± 8.7 21.2 ± 10.0 NS
After RRT
 PLT 93.7 ± 57.7 100.6 ± 67.7 NS 152.6 ± 106.0 125.2 ± 68.1 NS
 Hb 84.7 ± 13.4 83.3 ± 14.8 NS 89.9 ± 15.1 86.8 ± 17.9 NS
 WBC X10^9 8.94 ± 5.16 8.22 ± 4.40 NS 8.81 ± 4.62 10.3 ± 5.4 NS
 PT 13.63 ± 4.22 13.00 ± 2.86 NS 13.0 ± 1.8 13.4 ± 4.1 NS
 APTT 48.5 ± 44.01 34.78 ± 6.16 NS 33.7 ± 9.3 30.1 ± 5.1 NS
 ALB 33.8 ± 4.7 33.9 ± 4.5 NS 28.2 ± 5.6 29.4 ± 5.5 NS
 SCr 241.7 ± 186.4 252.5 ± 199.4 NS 260.1 ± 151.8 279.2 ± 179.8 NS
 BUN 12.5 ± 5.8 21.1 ± 31.6 NS 15.2 ± 7.1 15.9 ± 7.8 NS
clotting grades of filters 0/1/2/3 2/7/8/12 5/10/5/10   0/0/1/23 0/2/2/23  
Vein well cloting 0/1 29/1 29/1   22/2 24/3